- Gerrit de Boer, (Chairman)
Fiscal education at the Ministry of Finance and Chartered Accountant (certificate 1973). Various positions at the tax division of the Ministry of Finance (1970-1977). Tax Consultant (1978 -1980) and Partner PricewaterhouseCoopers (1981-2002). Chairman of the Board of PwC Tax Lawyers, Member of the Managing Board of PwC, Member of the International Middle Market Committee (PwC includes the pre-merger firms). From 2003 to date consultant to various family owned companies, advisory board member of various non-profit organizations.
- Cornelie E. Ritsma, MSc
Master’s degree in Medical Biology and Advanced Managed Program at Harvard Business School in Boston. Past: Over 25 years of experience in the international pharmaceutical industry in specialty, generics and OTC. From 2006 till 2015 with Teva Pharmaceuticals in various global and European roles, among which, SVP Global Strategic Initiatives, SVP Generics Europe, SVP Specialty Europe, VP & Chief Integration Officer Europe and member of Teva’s European Executive Team and Global Generic Leadership Team. From 1991 till 2006 in numerous senior positions in strategy, marketing & sales with GlaxoSmithKline, the Netherlands and Centre of Excellence Respiratory Europe. Present: Consultant to advice and supervise various healthcare related companies, (small) biotech & pharma and private equity companies.